Indeed, inhibition of surface GRP78 by polyclonal N-20 antibody treatment suppressed glioma cell survival and growth, showing great potential for use in cancer-specific therapy (Fig. 4). The gene discussed is HSPA5; the disease is central nervous system cancer.